Literature DB >> 379642

Heterogeneity of diffuse "histiocytic" lymphoma according to the Kiel classification.

P Meusers, H Bartels, G Brittinger, H Common, E Dühmke, H H Fülle, U Gunzer, R Heniz, E König, K Musshoff, H Pralle, U Schmalhorst, H Theml, G R Krüger, K Lennert.   

Abstract

Entities:  

Mesh:

Year:  1979        PMID: 379642     DOI: 10.1056/NEJM197908163010714

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Principles and present status of a prospective multicenter study on the clinical relevance of the Kiel classification.

Authors:  G Brittinger; U Schmalhorst; H Bartels; H H Fülle; H Gerhartz; G Gremmel; T Grisar; H J Grupp; U Gunzer; D Huhn; K M Koeppen; B Kubanek; H Leopold; H Löffler; G W Löhr; L Nowicki; U Rühl; M Schmidt; A Stacher; H Theml; K Lennert
Journal:  Blut       Date:  1981-09

2.  Diagnostic and therapeutic problems in non-Hodgkin lymphomas.

Authors:  K Musshoff; H Brücher
Journal:  Blut       Date:  1981-09

3.  Investigation results of a comparison made between the Kiel and Rappaport classifications of the non-Hodgkin's lymphomas, together with clinical data.

Authors:  K Musshoff; W von Stotzingen; H Schmidt-Vollmer; H Umbach
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

4.  J-chain-producing immunoblastic lymphoma in a case of Richter's syndrome. Immunohistochemical evidence for a gradual malignant transformation of a single B-cell clone and flow cytophotometric data.

Authors:  P Möller; G E Feichter; D Fritze; D Haag; B Schüle
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

5.  Histopathological correlation of the Kiel with the original Rappaport classification of malignant non-hodgkin lymphomas.

Authors:  G R Krüger; T Grisar; K Lennert; E W Schwarze; G Brittinger
Journal:  Blut       Date:  1981-09

6.  Clinical and prognostic heterogeneity of non-Hodgkin lymphomas of high-grade malignancy.

Authors:  U Schmalhorst; H Bartels; I Boll; A Burger-Schüler; H Common; H H Fülle; M Graubner; R Heinz; D Huhn; H Leopold; P Meusers; L Nowicki; R Nürnberger; J Oertel; U Rühl; G Sieber; M Schmidt; A Schoengen; A Strassner; E W Schwarze; G Brittinger
Journal:  Blut       Date:  1981-09

7.  CHOP-firstline treatment in NHL with unfavorable prognosis--evaluation of therapeutic response and factors influencing prognosis.

Authors:  R Heinz; E Neumann; P Aiginger; J Pont; J Schüller; G Walcher; H Hanak; T Radaszkiewicz; E Sinn; M Wirth
Journal:  Blut       Date:  1985-05

8.  Prognostic factors in non-Hodgkin's lymphoma: the importance of symptomatic stage as an adjunct to the Kiel histopathological classification.

Authors:  R C Leonard; J Cuzick; I C MacLennan; R I Vanhegan; P H Mackie; C V McCormick
Journal:  Br J Cancer       Date:  1983-01       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.